Suppr超能文献

[肺癌患者支气管镜刷检样本中端粒酶活性的检测]

[Detection of telomerase activity in bronchoscopic brush-off samples in patients with lung cancer].

作者信息

Yan Yu-lan, Zheng Jin-xu, Wang Xu, Wang Yi, Yang Jian-Yin

机构信息

Department of Pulmonary Medicine, Affiliated Hospital of Zhenjiang Medical College, Zhenjiang 212001, P. R. China.

出版信息

Ai Zheng. 2002 Jul;21(7):768-71.

Abstract

BACKGROUND AND OBJECTIVE

Recent studies have shown that activation of telomerase plays an important role in carcinogenesis. However, there was few report on the level of telomerase activity in small samples from the patients with lung cancer. This study was designed to investigate the diagnostic significance of the detection of telomerase activity in bronchoscopic brush-off cells from the patients with lung cancer.

METHODS

Telomeric repeat amplification protocol(TRAP)-based telomerase polymerase chain reaction(PCR)-enzyme-linked immunosorbent assay (ELISA) TRAP-PCR-silver staining were employed to detect telomerase activity in 56 samples of brushing cells from the patients with lung cancer and 10 samples with inflammation.

RESULTS

The positive rate of telomerase activity in 56 biopsy samples of lung cancer group was significantly higher than that in inflammation group (P < 0.001). The sensitivity, specificity, and accuracy of detection of telomerase activity was 87.5%, 83.3%, and 86.3%, respectively. There was no significant difference in the positive rate of telomerase activity between central lung cancer and peripheral lung cancer. Positive rate of detection of telomerase activity in bronchoscopic brush-off cells was 46.4%. The positive rate of telomerase activity detected in TRAP-PCR-ELISA was higher than that detected in TRAP-silver staining, but the significant difference was not found. It was found that samples with low absorbing value detected in the quantified way would show weak positive with less ladder bands or vague ladder bands if detected in the latter way.

CONCLUSION

The telomerase activity may be a good marker for diagnosis of lung cancer. Combined with cytologic measure, it is possible to raise the early diagnostic rate of lung cancer.

摘要

背景与目的

近期研究表明端粒酶激活在致癌过程中起重要作用。然而,关于肺癌患者小样本中端粒酶活性水平的报道较少。本研究旨在探讨检测肺癌患者支气管刷检细胞中端粒酶活性的诊断意义。

方法

采用基于端粒重复序列扩增法(TRAP)的端粒酶聚合酶链反应(PCR)-酶联免疫吸附测定(ELISA)TRAP-PCR-银染法检测56例肺癌患者刷检细胞样本及10例炎症患者样本中的端粒酶活性。

结果

肺癌组56例活检样本中端粒酶活性阳性率显著高于炎症组(P < 0.001)。端粒酶活性检测的灵敏度、特异度和准确度分别为87.5%、83.3%和86.3%。中心型肺癌与周围型肺癌端粒酶活性阳性率无显著差异。支气管刷检细胞中端粒酶活性检测阳性率为46.4%。TRAP-PCR-ELISA法检测的端粒酶活性阳性率高于TRAP-银染法,但差异无统计学意义。发现定量检测中吸光度值低的样本,若采用后一种方法检测会显示弱阳性,梯带较少或模糊。

结论

端粒酶活性可能是肺癌诊断的良好标志物。结合细胞学检测方法,有可能提高肺癌的早期诊断率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验